These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5932419)

  • 1. [Demonstration of the heterogeneity of "hyperlipemia" by identification of specific lipid particles].
    Laudat P; Koenig J; de Gennes JL
    Presse Med (1893); 1966 May; 74(26):1361-4. PubMed ID: 5932419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophoretic lipoprotein patterns and hyperlipemia].
    Arima T; Yamazaki S
    Rinsho Byori; 1972 Jan; 20(1):44-8. PubMed ID: 5063734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies, in dogs, on the pathogenesis of nephrotic hyperlipemia].
    PEZOLD FA; von KNORRE H; STEIN F; OEFF K; MUELLER LF; SAAR C
    Z Gesamte Exp Med; 1962; 136():248-73. PubMed ID: 13943030
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum-lipid reducing principles--possibilities for treatment. 2. Classification of hyperlipidemia].
    Boberg J; Gustafson A
    Lakartidningen; 1970 Dec; 67():Suppl IV:40+. PubMed ID: 5511951
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of qualitative changes in lipoproteins in experimental hyperlipemia].
    Scheiffarth F; Götz H; Griehl H
    Z Klin Chem Klin Biochem; 1968 Mar; 6(2):89-92. PubMed ID: 5707955
    [No Abstract]   [Full Text] [Related]  

  • 6. [Broad beta band disease. Description of a case].
    Infortuna M; Cordaro V
    Minerva Pediatr; 1974 Apr; 26(12):615-8. PubMed ID: 4376207
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity].
    Beaumont JL; Poullin MF; Jacotot B; Beaumont V
    Nouv Rev Fr Hematol; 1967; 7(4):481-98. PubMed ID: 4228342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Idiopathic hyperlipemia. Proposition of a simplified classification].
    de Gennes JL
    Presse Med (1893); 1971 Apr; 79(18):791-5. PubMed ID: 5574508
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intermittent cerebral symptoms in hyperlipemia type V].
    Harcos P; Márkus A; PETER A; Pucsol J
    Orv Hetil; 1975 Jul; 116(27):1589-92. PubMed ID: 1143850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification and etiology of hyperlipemia].
    Goto Y; Katayama T; Nakamura H; Hata Y; Goto M
    Naika; 1968 Oct; 22(4):812-8. PubMed ID: 5707870
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunization and hyperlipemia].
    Tayeau F; Jouzier E; Séchet J
    Bull Acad Natl Med; 1971 Dec; 155(32):819-23. PubMed ID: 4948735
    [No Abstract]   [Full Text] [Related]  

  • 12. [Etiologic mechanisms of carbohydrate-induced hyperlipemia].
    Liapkov BG; Markelova VF
    Biull Eksp Biol Med; 1981 May; 91(5):566-8. PubMed ID: 7020794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary disorders of the serum lipoproteins in childhood.
    Wolff OH
    Pediatrics; 1967 Jul; 40(1):1-4. PubMed ID: 6028894
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of primary hyperlipemia].
    Schneider J; Kaffarnik H
    Dtsch Med Wochenschr; 1971 Oct; 96(44):1731-2. PubMed ID: 5111789
    [No Abstract]   [Full Text] [Related]  

  • 16. [Binding capacity of plasma for fatty acids in idiopathic hyperlipemia].
    Kucerová L; Fabian E; Hoenig V; Sponarová J
    Sb Lek; 1967; 69(11):322-7. PubMed ID: 6076970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation of benign prostatic hyperplasia with hyperlipemia].
    Li PJ; Zhang XH; Guo LJ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):387-9. PubMed ID: 15854349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipemia of antiserum nephrosis. III. Plasma lipoproteins.
    SODHI HS; KALANT N
    Metabolism; 1963 May; 12():420-7. PubMed ID: 13989825
    [No Abstract]   [Full Text] [Related]  

  • 19. [ESSENTIAL HYPERLIPEMIA, TREATED WITH TRIIODOTHYROPROPIONIC ACID].
    JORGENSEN AW
    Ugeskr Laeger; 1964 Nov; 126():1516-8. PubMed ID: 14237263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid disturbances in diabetes mellitus--pathomechanism and treatment].
    Ciechanowski K; Ciechanowicz A
    Wiad Lek; 1993 Apr; 46(7-8):297-300. PubMed ID: 8249419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.